Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Pharmacological Reviews
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Pharmacological Reviews

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit Pharm Rev on Facebook
  • Follow Pharm Rev on Twitter
  • Follow ASPET on LinkedIn
Research ArticleSpecial Issue IUPHAR Compendium of the Pharmacology and Classification of the Nuclear Receptor Superfamily 2006

International Union of Pharmacology. LXII. The NR1H and NR1I Receptors: Constitutive Androstane Receptor, Pregnene X Receptor, Farnesoid X Receptor α, Farnesoid X Receptor β, Liver X Receptor α, Liver X Receptor β, and Vitamin D Receptor

David D. Moore, Shigeaki Kato, Wen Xie, David J. Mangelsdorf, Daniel R. Schmidt, Rui Xiao and Steven A. Kliewer
Pharmacological Reviews December 2006, 58 (4) 742-759; DOI: https://doi.org/10.1124/pr.58.4.6
David D. Moore
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas (D.D.M., R.X.); The Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo, Japan (S.K.); Center for Pharmacogenetics, University of Pittsburgh, Pittsburgh, Pennsylvania (W.X.); Howard Hughes Medical Institute, Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S.); and Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S., S.A.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shigeaki Kato
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas (D.D.M., R.X.); The Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo, Japan (S.K.); Center for Pharmacogenetics, University of Pittsburgh, Pittsburgh, Pennsylvania (W.X.); Howard Hughes Medical Institute, Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S.); and Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S., S.A.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wen Xie
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas (D.D.M., R.X.); The Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo, Japan (S.K.); Center for Pharmacogenetics, University of Pittsburgh, Pittsburgh, Pennsylvania (W.X.); Howard Hughes Medical Institute, Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S.); and Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S., S.A.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David J. Mangelsdorf
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas (D.D.M., R.X.); The Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo, Japan (S.K.); Center for Pharmacogenetics, University of Pittsburgh, Pittsburgh, Pennsylvania (W.X.); Howard Hughes Medical Institute, Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S.); and Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S., S.A.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel R. Schmidt
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas (D.D.M., R.X.); The Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo, Japan (S.K.); Center for Pharmacogenetics, University of Pittsburgh, Pittsburgh, Pennsylvania (W.X.); Howard Hughes Medical Institute, Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S.); and Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S., S.A.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rui Xiao
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas (D.D.M., R.X.); The Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo, Japan (S.K.); Center for Pharmacogenetics, University of Pittsburgh, Pittsburgh, Pennsylvania (W.X.); Howard Hughes Medical Institute, Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S.); and Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S., S.A.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven A. Kliewer
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas (D.D.M., R.X.); The Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo, Japan (S.K.); Center for Pharmacogenetics, University of Pittsburgh, Pittsburgh, Pennsylvania (W.X.); Howard Hughes Medical Institute, Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S.); and Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S., S.A.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 58 no. 4 742-759
DOI 
https://doi.org/10.1124/pr.58.4.6
PubMed 
17132852

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0031-6997
Online ISSN 
1521-0081
History 
  • Published online November 28, 2006.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. David D. Moore,
  2. Shigeaki Kato,
  3. Wen Xie,
  4. David J. Mangelsdorf,
  5. Daniel R. Schmidt,
  6. Rui Xiao, and
  7. Steven A. Kliewer
  1. Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas (D.D.M., R.X.); The Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo, Japan (S.K.); Center for Pharmacogenetics, University of Pittsburgh, Pittsburgh, Pennsylvania (W.X.); Howard Hughes Medical Institute, Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S.); and Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S., S.A.K.)
  1. Address correspondence to: Dr. David D. Moore, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030. E-mail: moore{at}bcm.tmc.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: November 2006 to January 2021

AbstractFullPdf
Nov 200651870
Dec 200642208243
Jan 200748163183
Feb 200735103143
Mar 200732115136
Apr 200731113103
May 2007188697
Jun 2007177669
Jul 2007187672
Aug 2007226273
Sep 2007155973
Oct 2007166863
Nov 2007126565
Dec 2007126266
Jan 2008287171
Feb 2008246070
Mar 2008236157
Apr 2008426056
May 2008465560
Jun 2008145536
Jul 2008456564
Aug 2008728244
Sep 2008326652
Oct 2008344055
Nov 2008375959
Dec 2008173446
Jan 2009224449
Feb 2009284764
Mar 20091024849
Apr 2009253759
May 2009214541
Jun 2009183844
Jul 2009151839
Aug 2009172833
Sep 2009203444
Oct 2009283837
Nov 2009263140
Dec 2009622229
Jan 20101032936
Feb 20101092432
Mar 2010732737
Apr 2010671927
May 2010795546
Jun 2010942029
Jul 2010482925
Aug 2010813324
Sep 2010531826
Oct 2010542627
Nov 2010572928
Dec 2010441927
Jan 2011491523
Feb 2011473129
Mar 2011422442
Apr 2011322632
May 2011491635
Jun 2011582226
Jul 2011722424
Aug 2011783433
Sep 2011543621
Oct 20111013633
Nov 2011772926
Dec 2011562324
Jan 2012943235
Feb 2012812334
Mar 2012902527
Apr 2012781820
May 2012922721
Jun 2012622923
Jul 2012752922
Aug 2012452225
Sep 2012413219
Oct 2012932735
Nov 2012982835
Dec 2012633128
Jan 2013744228
Feb 2013552418
Mar 2013783919
Apr 20131165331
May 2013783830
Jun 2013451823
Jul 2013551719
Aug 201355368
Sep 2013703520
Oct 2013643918
Nov 2013895141
Dec 2013665229
Jan 2014597324
Feb 2014515215
Mar 2014583021
Apr 2014604121
May 2014533628
Jun 2014393320
Jul 2014652124
Aug 2014392123
Sep 2014323636
Oct 2014442525
Nov 2014353721
Dec 2014427124
Jan 2015584326
Feb 2015381824
Mar 2015634145
Apr 2015673919
May 2015612228
Jun 2015472712
Jul 2015441912
Aug 2015401914
Sep 2015212514
Oct 2015401110
Nov 2015364938
Dec 201554194174
Jan 20161114030
Feb 2016891416
Mar 2016883025
Apr 20161072626
May 2016662540
Jun 2016412826
Jul 2016281827
Aug 2016432339
Sep 2016501440
Oct 2016169356
Nov 20161811148
Dec 2016135261
Jan 201717464
Feb 201773958
Mar 201793776
Apr 201734954
May 201713428
Jun 201733130
Jul 201755542
Aug 201734630
Sep 201767032
Oct 201735241
Nov 201745544
Dec 201755917
Jan 20189377
Feb 201845232
Mar 201894523
Apr 2018013617
May 201814612
Jun 201802717
Jul 201823519
Aug 201812012
Sep 201813310
Oct 201833013
Nov 201813116
Dec 201857178
Jan 20194932
Feb 20197821
Mar 20195953
Apr 20194322
May 20193372
Jun 20195475
Jul 20192621
Aug 20193844
Sep 20193310
Oct 20192221
Nov 20196253
Dec 201914543
Jan 202014001
Feb 202024300
Mar 202019132
Apr 20208453
May 20207155
Jun 20201511
Jul 20203841
Aug 20201925
Sep 20203454
Oct 20202994
Nov 202071920
Dec 202094315
Jan 202142012

PreviousNext
Back to top

In this issue

Pharmacological Reviews: 58 (4)
Pharmacological Reviews
Vol. 58, Issue 4
1 Dec 2006
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Pharmacological Reviews article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
International Union of Pharmacology. LXII. The NR1H and NR1I Receptors: Constitutive Androstane Receptor, Pregnene X Receptor, Farnesoid X Receptor α, Farnesoid X Receptor β, Liver X Receptor α, Liver X Receptor β, and Vitamin D Receptor
(Your Name) has forwarded a page to you from Pharmacological Reviews
(Your Name) thought you would be interested in this article in Pharmacological Reviews.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleSpecial Issue IUPHAR Compendium of the Pharmacology and Classification of the Nuclear Receptor Superfamily 2006

International Union of Pharmacology. LXII. The NR1H and NR1I Receptors: Constitutive Androstane Receptor, Pregnene X Receptor, Farnesoid X Receptor α, Farnesoid X Receptor β, Liver X Receptor α, Liver X Receptor β, and Vitamin D Receptor

David D. Moore, Shigeaki Kato, Wen Xie, David J. Mangelsdorf, Daniel R. Schmidt, Rui Xiao and Steven A. Kliewer
Pharmacological Reviews December 1, 2006, 58 (4) 742-759; DOI: https://doi.org/10.1124/pr.58.4.6

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleSpecial Issue IUPHAR Compendium of the Pharmacology and Classification of the Nuclear Receptor Superfamily 2006

International Union of Pharmacology. LXII. The NR1H and NR1I Receptors: Constitutive Androstane Receptor, Pregnene X Receptor, Farnesoid X Receptor α, Farnesoid X Receptor β, Liver X Receptor α, Liver X Receptor β, and Vitamin D Receptor

David D. Moore, Shigeaki Kato, Wen Xie, David J. Mangelsdorf, Daniel R. Schmidt, Rui Xiao and Steven A. Kliewer
Pharmacological Reviews December 1, 2006, 58 (4) 742-759; DOI: https://doi.org/10.1124/pr.58.4.6
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Structures
    • Endogenous Ligands
    • Synthetic Ligands and Selective Modulators
    • Genetics
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors
  • International Union of Pharmacology. LXIII. Retinoid X Receptors
Show more Special Issue IUPHAR Compendium of the Pharmacology and Classification of the Nuclear Receptor Superfamily 2006

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Pharmacological Reviews
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacology Research & Perspectives
ISSN 1521-0081 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics